Total submissions: 4
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Gene |
RCV000432145 | SCV000521743 | likely benign | not specified | 2015-12-04 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
| Labcorp Genetics |
RCV002062457 | SCV002481082 | likely benign | Naxos disease; Arrhythmogenic right ventricular dysplasia 12 | 2024-03-04 | criteria provided, single submitter | clinical testing | |
| Ce |
RCV004597797 | SCV005092736 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | JUP: BP4, BP7 |
| Ambry Genetics | RCV005348115 | SCV006019325 | likely benign | Cardiovascular phenotype | 2025-01-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |